Individuals with severe/critical symptoms and relevant history of travel and/or contact.
Individuals with mild symptoms and relevant history of travel and/or contact, and considered vulnerable; vulnerable populations include those elderly and with preexisting medical conditions that predispose them to severe presentation and complications of COVID-19
Individuals with mild symptoms, and relevant history of travel and/or contact.
Individuals with no symptoms but with relevant history of travel and/or contact or high risk of exposure. These include:
Frontliners indirectly involved in health care provision in the response against COVID-19 may be tested as follows:
Other vulnerable patients and those living in confined spaces. These include, but are not limited to:
Residents, occupants or workers in a localized area with an active COVID-19 cluster, as identified and declared by the local chief executive in accordance with existing DOH Guidelines and consistent with the National Task Force Memorandum Circular No. 02 s.2020 or the Operational Guidelines on the Application of the Zoning Containment Strategy in the Localization of the National Action Plan Against COVID-19 Response. The local chief executive shall conduct the necessary testing in order to protect the broader community and critical economic activities and to avoid a declaration of a wider community quarantine.
Frontliners in Tourist Zones:
All workers and employees of manufacturing companies and public service providers registered in economic zones located in Special Concern Areas may be tested regularly.
Economy Workers
A person with laboratory confirmation of COVID-19 infection, irrespective of clinical signs and symptoms.
1 Signs separated with slash (/) are to be counted as one sign
2 Community transmission: Countries /territories/areas experiencing larger outbreaks of local transmission defined through an assessment of factors including, but not limited to: large numbers of cases not linkable to transmission chains, large numbers of cases from sentinel lab surveillance or increasing positive tests through sentinel samples (routine systematic testing of respiratory samples from established laboratories), multiple unrelated clusters in several areas of the country/territory/area.
Symptomatic patients presenting with fever, cough, fatigue, anorexia, myalgias; other non-specific symptoms such as sore throat, nasal congestion, headache, diarrhea, nausea and vomiting; loss of smell (anosmia) or loss of taste (ageusia) preceding the onset of respiratory symptoms with NO signs of pneumonia or hypoxia
Patients manifesting with acute respiratory distress syndrome, sepsis and/or septic shock:
Please wait while we save your questionnaire answers (do not navigate away from the page).